ESMO 2023

Research and breaking news from the European Society for Medical Oncology Congress, taking place in Madrid, Spain, October 20-24, 2023.

Pancreatic Enzyme Replacement Therapy for Patients With Advanced Pancreatic Adenocarcinoma
Pancreatic Enzyme Replacement Therapy for Patients With Advanced Pancreatic Adenocarcinoma
Katy MarshallESMO Congress 2023 | November 3, 2023
Participating patients received PERT at baseline or within 3 months of receiving first-line treatment.
CABINET: Does Cabozantinib Benefit Patients With Advanced Pancreatic Neuroendocrine Tumors?
CABINET: Does Cabozantinib Benefit Patients With Advanced Pancreatic Neuroendocrine Tumors?
Katy MarshallESMO Congress 2023 | November 3, 2023
Researchers analyzed cabozantinib's ability to improve the progression-free survival rate for patients.
Advertisement
Advertisement
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |